Glenn Whaley
Fortuna: 142 883 $ al 31/05/2026
Fortuna: 142 883 $ al 31/05/2026
Mr. Glenn Whaley, CPA, is a Chief Financial Officer at Immunic, Inc., a Member at New Jersey Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Whaley was previously employed as a Chief Financial Officer by Pernix Therapeutics Holdings, Inc., a Vice President-Finance by Alvogen, Inc., and a Controller by ImClone Systems, Inc. He received his undergraduate degree from Rutgers Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNIC, INC. 0,07 % | 26/05/2026 | 9.551 ( 0,07 % ) | 142 883 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNIC, INC. | Director Financiero/CFO | 17/04/2020 |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/03/2015 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Comptroller/Controller/Auditor | 01/05/2011 |
| PERNIX THERAPEUTICS HOLDINGS INC | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.